Xtant Medical Holdings, Inc.

Historical 13F Holders

Symbol
XTNT
CUSIP
98420P308
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 98420P308 since 12/18/2024, newest first.

Filer % of Class Filed
Lytton Laurence W 13G/A Amendment 1
5.5% 2/17/2026
Event 12/31/2025
Nantahala Capital Management, LLC 13D/A Amendment 1
49.1% 8/5/2025
Event 8/1/2025
Nantahala Capital Management, LLC 13D
49.1% 4/17/2025
Event 4/10/2025
Laurence W. Lytton 13G 6.8% 4/16/2025
Event 4/15/2025
Orbimed Advisors LLC 13D/A Amendment 13
0% 4/14/2025
Event 4/10/2025
Nantahala Capital Management, LLC 13G
8.2% 11/14/2024
Event 9/30/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 2.30 k $816.00
2026 Q2 33 149 M $62.6 M
2026 Q1 34 80.7 M $45.1 M
2025 Q4 36 81.8 M $64.1 M
2025 Q3 31 80.1 M $52.0 M
2025 Q2 31 80.0 M $59.1 M
2025 Q1 29 96.3 M $45.3 M
2024 Q4 31 96.7 M $42.8 M
2024 Q3 30 98.2 M $66.1 M
2024 Q2 30 93.6 M $59.0 M
2024 Q1 37 90.4 M $106 M
2023 Q4 35 94.2 M $106 M
2023 Q3 29 90.3 M $99.3 M
2023 Q2 20 81.8 M $76.0 M
2023 Q1 22 81.9 M $52.2 M
2022 Q4 21 81.9 M $54.1 M
2022 Q3 19 81.7 M $58.8 M
2022 Q2 19 80.6 M $41.9 M
2022 Q1 20 80.5 M $54.8 M
2021 Q4 24 80.7 M $45.2 M
2021 Q3 18 80.5 M $89.4 M
2021 Q2 21 82.7 M $135 M
2021 Q1 22 74.5 M $176 M
2020 Q4 20 73.8 M $88.2 M
2020 Q3 20 10.1 M $8.35 M
2020 Q2 19 10.3 M $9.31 M
2020 Q1 19 11.7 M $7.82 M
2019 Q4 15 11.7 M $18.7 M
2019 Q3 15 11.7 M $33.2 M
2019 Q2 14 11.7 M $35.0 M
2019 Q1 13 11.7 M $35.6 M
2018 Q4 16 11.7 M $18.9 M
2018 Q3 17 11.7 M $45.0 M
2018 Q2 15 11.0 M $60.9 M
2018 Q1 13 10.6 M $83.1 M